Promising survival rate but high incidence of treatment‐related mortality after reduced‐dose craniospinal radiotherapy and tandem high‐dose chemotherapy in patients with high‐risk medulloblastoma-Reference-Cited by-同舟云学术

Promising survival rate but high incidence of treatment‐related mortality after reduced‐dose craniospinal radiotherapy and tandem high‐dose chemotherapy in patients with high‐risk medulloblastoma

Published:2020-06-30 Issue:16 Volume:9 Page:5807-5818
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Lee Ji Won¹^ORCID,Lim Do Hoon²^ORCID,Sung Ki Woong¹^ORCID,Cho Hee Won¹^ORCID,Ju Hee Young¹^ORCID,Hyun Ju Kyung¹^ORCID,Yoo Keon Hee¹^ORCID,Koo Hong Hoe¹^ORCID,Suh Yeon‐Lim³^ORCID,Joung Yoo‐Sook⁴^ORCID,Shin Hyung Jin⁵^ORCID

Affiliation:

1. Department of Pediatrics Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Republic of Korea

2. Department of Radiation Oncology Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Republic of Korea

3. Department of Pathology Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Republic of Korea

4. Department of Psychiatry Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Republic of Korea

5. Department of Neurosurgery Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Republic of Korea

Funder

Ministry of Health and Welfare

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3199

Reference33 articles.

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011

Medulloblastoma: optimizing care with a multidisciplinary approach

3. Medulloblastoma

4. Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters

5. A phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high‐risk medulloblastoma (protocol POG 9631): a report from the Children's Oncology Group;Esbenshade AJ;Pediatr Blood Cancer,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Medulloblastoma in the Adolescent and Young Adult Population: A Systematic Review;Journal of Adolescent and Young Adult Oncology;2024-08-23

3. Long-term Outcomes of Protocol-based Treatment for Newly Diagnosed Medulloblastoma;Cancer Research and Treatment;2023-11-30

4. Multiparametric MRI-Based Radiomics Signature with Machine Learning for Preoperative Prediction of Prognosis Stratification in Pediatric Medulloblastoma;Academic Radiology;2023-08

5. Questions and answers in the management of children with medulloblastoma over the time. How did we get here? A systematic review;Frontiers in Oncology;2023-06-29